S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
NYSE:ENZ

Enzo Biochem (ENZ) Stock Price, News & Analysis

$1.27
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$1.27
$1.29
50-Day Range
$1.22
$1.39
52-Week Range
$1.16
$2.74
Volume
45,471 shs
Average Volume
90,383 shs
Market Capitalization
$65.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ENZ stock logo

About Enzo Biochem Stock (NYSE:ENZ)

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

ENZ Stock Price History

ENZ Stock News Headlines

Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Drops By 9.8%
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Enzo Biochem: Fiscal Q2 Earnings Snapshot
Enzo Biochem, Inc.
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Jim Simons Trims Stake in Enzo Biochem Inc
Enzo Biochem Appoints New CEO and CFO
Enzo Biochem Inc (EZB.SG)
Enzo Biochem Inc ENZ
See More Headlines
Receive ENZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/15/2019
Today
3/28/2024
Next Earnings (Estimated)
6/12/2024
Fiscal Year End
7/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Employees
179
Year Founded
1976

Profitability

Net Income
$20.29 million
Pretax Margin
-71.07%

Debt

Sales & Book Value

Annual Sales
$31.06 million
Book Value
$1.38 per share

Miscellaneous

Free Float
43,286,000
Market Cap
$65.06 million
Optionable
Optionable
Beta
0.75

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

ENZ Stock Analysis - Frequently Asked Questions

How have ENZ shares performed in 2024?

Enzo Biochem's stock was trading at $1.39 on January 1st, 2024. Since then, ENZ shares have decreased by 8.6% and is now trading at $1.27.
View the best growth stocks for 2024 here
.

Are investors shorting Enzo Biochem?

Enzo Biochem saw a decline in short interest in the month of February. As of February 29th, there was short interest totaling 715,400 shares, a decline of 9.8% from the February 14th total of 792,900 shares. Based on an average daily trading volume, of 113,500 shares, the days-to-cover ratio is currently 6.3 days. Approximately 2.1% of the shares of the stock are sold short.
View Enzo Biochem's Short Interest
.

When is Enzo Biochem's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our ENZ earnings forecast
.

How were Enzo Biochem's earnings last quarter?

Enzo Biochem, Inc. (NYSE:ENZ) posted its earnings results on Tuesday, October, 15th. The medical research company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.03. The medical research company had revenue of $20.92 million for the quarter. Enzo Biochem had a net margin of 99.28% and a negative trailing twelve-month return on equity of 36.71%.

What other stocks do shareholders of Enzo Biochem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Enzo Biochem investors own include OneLife Technologies (OLMM), Gilead Sciences (GILD), OPKO Health (OPK), Teva Pharmaceutical Industries (TEVA), Inovio Pharmaceuticals (INO), AbbVie (ABBV), Pfizer (PFE), Advanced Micro Devices (AMD), Amarin (AMRN) and Micron Technology (MU).

Who are Enzo Biochem's major shareholders?

Enzo Biochem's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (3.72%), Vanguard Group Inc. (3.72%), Potomac Capital Management Inc. (2.93%), Dimensional Fund Advisors LP (1.45%), Northern Trust Corp (0.22%) and FNY Investment Advisers LLC (0.15%). Insiders that own company stock include Bradley Louis Radoff, David Bench, Hamid Erfanian, James G Wolf and Kara Cannon.
View institutional ownership trends
.

How do I buy shares of Enzo Biochem?

Shares of ENZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ENZ) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners